Filing Details

Accession Number:
0000899243-20-032605
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-02 21:00:09
Reporting Period:
2020-11-30
Accepted Time:
2020-12-02 21:00:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1351288 Gw Pharmaceuticals Plc GWPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754163 J. Christopher Tovey Sovereign House, Vision Park, Histon
Cambridge X0 CB24 9BZ
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-11-30 3,924 $0.00 6,420 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-30 10,452 $0.00 16,872 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-30 6,468 $0.00 23,340 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-30 57,684 $0.00 81,024 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-30 8,952 $0.00 89,976 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-30 5,988 $0.00 95,964 No 4 M Direct
Ordinary Shares Disposition 2020-11-30 93,468 $11.67 2,496 No 4 S Direct
Ordinary Shares Acquisiton 2020-12-01 28,560 $0.00 31,056 No 4 M Direct
Ordinary Shares Disposition 2020-12-01 19,500 $11.74 11,556 No 4 S Direct
Ordinary Shares Disposition 2020-12-01 9,060 $11.79 2,496 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Options Disposition 2020-11-30 3,924 $0.00 3,924 $0.00
Ordinary Shares Stock Options Disposition 2020-11-30 10,452 $0.00 10,452 $0.00
Ordinary Shares Stock Options Disposition 2020-11-30 6,468 $0.00 6,468 $0.00
Ordinary Shares Stock Options Disposition 2020-11-30 57,684 $0.00 57,684 $0.00
Ordinary Shares Stock Options Disposition 2020-11-30 8,952 $0.00 8,952 $0.00
Ordinary Shares Stock Options Disposition 2020-11-30 5,988 $0.00 5,988 $0.00
Ordinary Shares Stock Options Disposition 2020-12-01 28,560 $0.00 28,560 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6 2019-06-24 2025-06-24 No 4 M Direct
5 2020-02-15 2026-02-15 No 4 M Direct
0 2020-01-06 2027-01-06 No 4 M Direct
28,560 2020-01-06 2027-01-06 No 4 M Direct
0 2020-02-26 2028-02-26 No 4 M Direct
0 2020-03-01 2029-03-01 No 4 M Direct
0 2020-01-06 2027-01-06 No 4 M Direct
Footnotes
  1. Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
  2. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.33 U.S. Dollars as of November 30, 2020.
  3. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2020.
  4. Represented by ADSs.
  5. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($140.0338 per ADS). These shares were sold in multiple transactions at prices ranging from $140.00 per ADS (or $11.66 per ordinary share) to $140.25 per ADS (or $11.69 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range
  6. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.34 U.S. Dollars as of December 1, 2020.
  7. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($140.8760 per ADS). These shares were sold in multiple transactions at prices ranging from $140.40 per ADS (or $11.78 per ordinary share) to $141.31 per ADS (or $11.78 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range
  8. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($141.5258 per ADS). These shares were sold in multiple transactions at prices ranging from $141.40 per ADS (or $11.78 per ordinary share) to $142.00 per ADS (or $11.83 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  9. Reflects an adjustment to total holdings to exclude seven shares incorrectly included in prior reports.